Tandem Diabetes Care (TNDM) FCF Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly FCF Margin came in at 1.94% in Q1 2026, up 1100.0% YoY from 0.16% in Q1 2025, and up 81.11% on a QoQ basis from 1.07% in Q4 2025.
Tandem Diabetes Care (TNDM) FCF Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of FCF Margin data on file, last reported at 1.94% in Q1 2026.
- Quarterly FCF Margin rose 1100.0% year-over-year to 1.94% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.35% (down 189.0% YoY) and the FY2025 annual result came in at 2.92%, down 560.0% from the prior year.
- FCF Margin climbed to 1.94% in Q1 2026, from 1.07% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 11.85% in Q3 2022 to a low of 16.03% in Q1 2023.
- A 5-year average of 0.1% and a median of 1.07% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin plunged 2355 bps — and 2024, when it soared 1437 bps.
- Tracing TNDM's FCF Margin over 5 years: stood at 2.53% in 2022, then sank by 280 bps to 4.55% in 2023, then jumped by 316 bps to 9.83% in 2024, then plunged by 89 bps to 1.07% in 2025, then surged by 81 bps to 1.94% in 2026.
- The last three FCF Margin figures came in at 1.94% (Q1 2026), 1.07% (Q4 2025), and 1.58% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.73% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | -14.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.63% |
| Mar 31, 2026 | 1.94% |
| Dec 31, 2025 | 1.07% |
| Sep 30, 2025 | -1.58% |
| Jun 30, 2025 | -3.16% |
| Mar 31, 2025 | -9.06% |
| Dec 31, 2024 | 9.83% |
| Sep 30, 2024 | 8.83% |
| Jun 30, 2024 | -5.85% |
| Mar 31, 2024 | -5.85% |
| Dec 31, 2023 | -4.55% |
| Sep 30, 2023 | 8.10% |
| Jun 30, 2023 | -6.99% |
| Mar 31, 2023 | -16.03% |
| Dec 31, 2022 | 2.53% |
| Sep 30, 2022 | 11.85% |
| Jun 30, 2022 | 3.11% |
| Mar 31, 2022 | 7.51% |
| Dec 31, 2021 | 8.93% |
| Sep 30, 2021 | 19.01% |